Citigroup Inc Vir Biotechnology, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Citigroup Inc holds 114,418 shares of VIR stock, worth $814,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,418

Previous 84,871 34.81%

Holding current value

$814,656

Previous $755,000 13.38%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.26 - $10.7 $214,511 - $316,152	29,547 Added 34.81%	114,418 $856,000
Q2 2024 Aug 12, 2024	SELL	$7.63 - $12.66 $7.93 Million - $13.2 Million	-1,039,860 Reduced 92.45%	84,871 $755,000
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $7.9 Million - $10.9 Million	918,710 Added 445.93%	1,124,731 $11.4 Million
Q4 2023 Feb 09, 2024	SELL	$7.76 - $10.29 $399,112 - $529,235	-51,432 Reduced 19.98%	206,021 $2.07 Million
Q3 2023 Nov 09, 2023	BUY	$9.14 - $24.62 $922,911 - $2.49 Million	100,975 Added 64.53%	257,453 $2.41 Million
Q2 2023 Aug 10, 2023	SELL	$23.2 - $27.29 $3.31 Million - $3.89 Million	-142,619 Reduced 47.68%	156,478 $3.84 Million
Q1 2023 May 11, 2023	BUY	$22.26 - $30.85 $2.37 Million - $3.28 Million	106,436 Added 55.25%	299,097 $6.96 Million
Q4 2022 Feb 09, 2023	SELL	$19.96 - $28.22 $2.52 Million - $3.56 Million	-126,119 Reduced 39.56%	192,661 $4.88 Million
Q3 2022 Nov 10, 2022	BUY	$18.26 - $31.1 $1.77 Million - $3.02 Million	97,130 Added 43.82%	318,780 $6.15 Million
Q2 2022 Aug 10, 2022	BUY	$19.08 - $26.7 $3.34 Million - $4.67 Million	174,980 Added 374.93%	221,650 $5.65 Million
Q1 2022 May 12, 2022	SELL	$21.19 - $40.01 $1.41 Million - $2.66 Million	-66,592 Reduced 58.79%	46,670 $1.2 Million
Q4 2021 Feb 10, 2022	BUY	$30.97 - $54.03 $75,814 - $132,265	2,448 Added 2.21%	113,262 $4.74 Million
Q3 2021 Nov 10, 2021	BUY	$34.9 - $54.54 $3.87 Million - $6.04 Million	110,814 New	110,814 $4.82 Million

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account